Experienced in Stasis Dermatitis and Ulcers

Naoki Matsumoto

Tokyo, JP 
Experienced in Stasis Dermatitis and Ulcers
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Naoki Matsumoto practices in Tokyo, Japan. Mr. Matsumoto is rated as an Experienced expert by MediFind in the treatment of Stasis Dermatitis and Ulcers. His top areas of expertise are Hepatitis A, Hepatic Hemangioma, Cirrhosis, Pancreaticoduodenectomy, and Thrombectomy.

His clinical research consists of co-authoring 195 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Stasis Dermatitis and Ulcers.

Gender
Male

Locations

Tokyo, Japan
Other Locations
Yokohama, 2448602, Japan
St. Marianna University School Of Medicine, 2-16-1 Sugao, Miyamae Ku, Kawasaki, 2168511, Japan
Numazu, Japan
Itabashi, 1738610, Japan
Sakuracho, 3388570, Japan
Higashi-osaka, Japan
Kashiwa, Japan
Chiyoda, Japan
Chiba, Japan
St. Marianna University School of Medicine
Kanagawa, Japan
Kamakura, Japan
Japan
Sapporo, Japan
Hongo, 1130033, Japan
Kusatsu, 5258577, Japan
Shibukawa, 3778577, Japan
St. Marianna University School Of Medicine, St. Marianna University Graduate School Of Medicine, Kumamoto, Japan
Itabashi, 1738610, Japan
Kobe, 6511102, Japan
Oyaguchi, 1738610, Japan
Yayoi, 1130032, Japan
Himeji, 6708520, Japan
Kyoto, Japan
Nakagawara, 1738610, Japan
Toranomon, Japan
Takasaki, 3700836, Japan
Fukaya, 3660052, Japan
Maebashi, Japan
Yamanashi, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

195 Total Publications

Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir-Velpatasvir Therapy.
Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir-Velpatasvir Therapy.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Matsumoto's expertise for a condition
ConditionClose
    View All 47 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile